Search - tctmd.com

Displaying 841 - 860 of 1290

Sort: Relevancy | Date

News Daily News

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

Yael L. Maxwell

November 08, 2015

News Daily News

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Shelley Wood

November 08, 2015

News Daily News

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

Yael L. Maxwell

November 03, 2015

News Daily News

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

L.A. McKeown

November 03, 2015

News Daily News

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

Yael L. Maxwell

October 30, 2015

News Daily News

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

Yael L. Maxwell

October 30, 2015

Presentation

ADAPT-DES Subanalaysis: Proton Pump Inhibitors (PPIs), Platelet Reactivity, and Cardiovascular Outcomes After DES in Clopidogrel-Treated Patients

Presenter: Giora Weisz

October 28, 2015

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Yael L. Maxwell

October 26, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

News Daily News

BMS 再见？新 DAPT 分析显示 DES 支架血栓形成率较低

Yael L. Maxwell

October 26, 2015

Presentation

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

Presenter: Dean J. Kereiakes

October 22, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Industry News

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

Advertisement

FDA: Long-Term Clopidogrel Neither Ups, Nor Cuts Risk of Death in CVD Patients

FDA：长期氯吡格雷既不增加也不降低心血管病患者死亡风险

CANOA: Fewer Migraines With Clopidogrel Plus Aspirin Post-ASD Closure

Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

Despite Drawbacks and Frustration, EHRs Could Have Meaningful Benefit in Acute MI Patients

A Pesar de la Frustración e Inconvenientes la HCE Podría Beneficiar a Pacientes IAM

ADAPT-DES Subanalaysis: Proton Pump Inhibitors (PPIs), Platelet Reactivity, and Cardiovascular Outcomes After DES in Clopidogrel-Treated Patients

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

BMS 再见？新 DAPT 分析显示 DES 支架血栓形成率较低

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content